ArticleCureus2025
Aortoenteric Fistula Formation From Chronic Erosion of an Axios Gastroduodenal Stent in a Patient With a History of Radiation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric outlet obstruction (GOO) secondary to malignant bowel obstruction (MBO) presents significant challenges in patients with advanced cancer, often impairing quality of life and nutritional intake. This report discusses a complex case of a 53-year-old male patient with stage IV colon cancer who developed an aortoenteric fistula (AEF) as a rare, life-threatening complication following duodenal stenting for GOO management. The case highlights the multifaceted etiology of AEF, involving prior radiation, chronic inflammation, and infected psoas abscess, culminating in massive gastrointestinal hemorrhage. While duodenal stents effectively restore luminal patency and alleviate symptoms in palliative settings, vigilant monitoring is crucial to promptly identifying and addressing potential complications, such as AEF. This underscores the need for a multidisciplinary approach in managing GOO in malignancy, balancing the benefits of self-expandable metallic stents (SEMS) against alternative interventions such as gastrojejunostomy (GJ), tailored to the patient's condition and prognosis to optimize outcomes and enhance quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.